Beginning January 7, 2008, Oracle Healthcare Acquisition Corp. (the “Company”) will hold meetings with certain investors regarding the proposed merger between PTI Acquisition Sub, Inc., a wholly owned subsidiary of the Company, and Precision Therapeutics, Inc. The presentation to be used in connection with such investor meetings is furnished as Exhibit 99.1 to this report.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
| Exhibit No. | Description: | |
| Exhibit 99.1 | Investor Presentation |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| ORACLE HEALTHCARE ACQUISITION CORP. | ||||
| Date: January 7, 2008 | By: | /s/ Joel D. Liffmann | ||
| Name: | Joel D. Liffmann | |||
| Title: | President and Chief Operating Officer | |||
INDEX TO EXHIBITS
| Exhibit No. | Description: | |
| Exhibit 99.1 | Investor Presentation |